U.S. Stocks Rise Amid More Deal News

NEW YORK (MarketWatch) -- U.S. stocks rose firmly on Wednesday, sending the Dow Jones Industrial Average to a new record high, as a stream of deal making news continued to fuel buying interest, this time with speculation in the metals sector after Alcan Inc. rejected Alcoa Inc.'s hostile bid.

"I wouldn't say this market is unstoppable, but there's certainly little resistance to the upside," said Art Hogan, chief market strategist at Jefferies & Co.

The Dow Jones Industrial Average was up 46 points at 13,587, after earlier hitting a new record high of 13,609. The advance was led by the likes of Caterpillar Inc. , Home Depot Inc. , Hewlett-Packard Co. and Disney .

"The real driver is this huge pool of liquidity out there, both in the coffers of companies that use it for share buybacks or acquisitions, and in the private world ,with a lot of take out activity," Hogan said.

Alcoa Inc. led the gains, rising 4%. Alcan late Tuesday rejected the $27 billion hostile offer from the Dow-component. Alcan rose 4.2%.

Separately, a newspaper report said that BHP Billiton has held early-stage talks with Alcan. Rio Tinto , which has also been rumored to be a target for BHP and for private equity interest, gained 1.8%. BHP gained 2.8%.

Also in the metals sector, Russia's Norilsk Nickel launched a new $6.25 billion offer for Canadian miner LionOre, topping an offer from Xstrata by 10%.

Elsewhere on the Dow, Boeing Co. fell 0.7% after reaffirming earnings guidance for 2007 and 2008.

The S&P 500 index gained 6.2 points to 1,530, putting it on track towards a record-high closing level. The previous record close of 1,527 was made in March 2000.

The Nasdaq Composite advanced 9.6 points to 2,597.

Trading volumes showed 788 million shares trading on the New York Stock Exchange and 1 billion trading on the Nasdaq stock market. Advancing issues outpaced decliners by 19 to 12 on the NYSE and by 4 to 3 on the Nasdaq.

By sector, metals mining stocks led the gains, along with oil services and broker dealers . Semiconductors and software were among the few sectors falling.

Chip stocks were pressured by Analog Devices , which slumped 10% after reporting a 14% profit decline and saying current quarter earnings will be below market estimates. Both JP Morgan and Credit Suisse downgraded the stock.

In the media sector, members of the Bancroft family, which controls Dow Jones , are reportedly due to discuss the News Corp. takeover bid at a meeting. Dow Jones owns MarketWatch, which publishes this report.

In other deal news, Crescent Real Estate Equities Co. agreed to be acquired by funds managed by Morgan Stanley Real Estate for $22.80 per share in a deal valued at roughly $6.5 billion, including debt. The offer represents a 5.5% premium over Crescent's closing share price on Tuesday.

Payless ShoeSource said it would buy Stride Rite for $800 million.

Other markets

With key U.S.-China economic talks entering their second day, investors will expect a statement to come out of Washington. Wall Street has viewed the talks as positive in easing rising trade tensions between China and the U.S.

With no major economic data on tap until durable goods and housing data on Thursday, bonds were down slightly, with the benchmark 10-year Treasury bond down 5/32 at 97 9/32, yielding 4.846%.

The dollar was down slightly against major counterparts.

Crude oil was little changed ahead of supply data expected to show a build in gasoline inventories. A barrel was recently up 2 cents at $65.53.

Corporate news

There are a number of retailers due to report quarterly results.

Target posted better-than-expected earnings of 75 cents a share but its revenue, at $14.04 billion, fell short of estimates. Analysts polled by Thomson Financial expected on average, first-quarter earnings of 71 cents a share on revenu of $14.17 billion.

Abercrombie & Fitch and Limited Brands are also due to report results.

Standard & Poor's said it would add Memc Electronic Materials Inc. to the S&P 500, replacing Kinder Morgan Inc., on a date to be announced.

Elsewhere, Medtronic rose 2.6% after the company's quarterly earnings and revenue outstripped analyst estimates.

CA and Network Appliance also are due to report quarterly results.

Forest Laboratories Inc. and Cypress Bioscience Inc. said a Phase III study of the company's milnacipran drug showed significant therapeutic effects in patients with fibromyalgia syndrome.

By Nick Godt